ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 686385 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 686385; 2) Community: the network communities that were significantly associated with the response to NSC 686385; 3) Molecule: the relationships between components within communities and NSC 686385; 4) MDR: the compounds that were significantly associated with the NSC 686385.

NSC Compound Enrichment Correlation
NSC 704286 Null 0.00126952303154153 0.18105225
NSC 706192 Null 0.00126952303154153 0.35410844
NSC 711611 Null 0.00126952303154153 0.3507512
NSC 711745 Null 0.00126952303154153 0.17064534
NSC 725191 1,6-bis[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(trifluorometh yl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexade c-9-en-9-yl]-3-hexene-1,6-diol 0.00126952303154153 0.1941906
NSC 736164 pyrazoline derivative 0.00126952303154153 0.42862395
NSC 740602 Null 0.00126952303154153 0.25110246
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.00126952303154153 0.42697656
NSC 149286 1,4-Pentadien-3-one, 1,5-di-3-pyridyl- 0.00126952303154154 0.40392283
NSC 169774 Bromocriptine methanesulfonate 0.00126952303154154 0.36385578
Total:149  Current:15    [First] [Prev] [Next] [Last]